The Role of 5-Hydroxytryptamine 7 Receptors in the Phencyclidine-Induced Novel Object Recognition Deficit in Rats (Q48137014)

9 February 2018

title

The role of 5-hydroxytryptamine 7 receptors in the phencyclidine-induced novel object recognition deficit in rats (English)

1 reference

9 February 2018

The Role of 5-Hydroxytryptamine 7 Receptors in the Phencyclidine-Induced Novel Object Recognition Deficit in Rats (English)

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1124/JPET.111.180638

1 December 2024

M. Horiguchi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21558435

1 December 2024

M. Huang

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21558435

1 December 2024

H. Y. Meltzer

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21558435

1 December 2024

language of work or name

English

0 references

publication date

10 May 2011

1 reference

9 February 2018

full work available at URL

https://syndication.highwire.org/content/doi/10.1124/jpet.111.180638

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1124/JPET.111.180638

Journal of Pharmacology and Experimental Therapeutics

1 December 2024

published in

1 reference

9 February 2018

volume

338

1 reference

9 February 2018

issue

1 reference

9 February 2018

page(s)

605-614

1 reference

9 February 2018

Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo

cites work

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Changes in neurocognitive function in patients with schizophrenia after starting or switching to amisulpride in comparison with the normal controls.

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Endogenous serotonin excites striatal cholinergic interneurons via the activation of 5-HT 2C, 5-HT6, and 5-HT7 serotonin receptors: implications for extrapyramidal side effects of serotonin reuptake inhibitors.

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

The FDA-NIMH-MATRICS guidelines for clinical trial design of cognitive-enhancing drugs: what do we know 5 years later?

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Glutamate and schizophrenia: beyond the dopamine hypothesis

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Lurasidone reverses MK-801-induced impairment of learning and memory in the Morris water maze and radial-arm maze tests in rats

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

5-HT7 receptor stimulation by 8-OH-DPAT counteracts the impairing effect of 5-HT(1A) receptor stimulation on contextual learning in mice

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Effect of 5-HT(7) antagonist SB-269970 in the modulation of working and reference memory in the rat

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Functional and Anatomical Aspects of Prefrontal Pathology in Schizophrenia

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat.

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

The acute effects of NMDA antagonism: from the rodent to the human brain

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine.

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Ionotropic glutamate receptor modulation of 5-HT6 and 5-HT7 mRNA expression in rat brain

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

The 5-HT7 receptor and disorders of the nervous system: an overview

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Functional, molecular and pharmacological advances in 5-HT7 receptor research

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Interaction of mGlu2/3 agonism with clozapine and lurasidone to restore novel object recognition in subchronic phencyclidine-treated rats

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Positive association of the serotonin 5-HT7 receptor gene with schizophrenia in a Japanese population

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Lurasidone (SM-13496), a novel atypical antipsychotic drug, reverses MK-801-induced impairment of learning and memory in the rat passive-avoidance test

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Recent advances in the phencyclidine model of schizophrenia

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970).

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Role of 5-HT receptor mechanisms in sub-chronic PCP-induced reversal learning deficits in the rat.

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Role of serotonin in the action of atypical antipsychotic drugs

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

The role of serotonin receptors in the action of atypical antipsychotic drugs

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Effects of the 5-HT7 receptor antagonists SB-269970 and DR 4004 in autoshaping Pavlovian/instrumental learning task

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Lurasidone: a new drug in development for schizophrenia

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Effects of the potential 5-HT7 receptor agonist AS 19 in an autoshaping learning task

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Effects of the 5-HT(7) receptor antagonist SB-258741 in animal models for schizophrenia

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Neuropsychological function in schizophrenia. Selective impairment in memory and learning

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Inactivation of the 5-HT(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Attenuation of phencyclidine-induced object recognition deficits by the combination of atypical antipsychotic drugs and pimavanserin (ACP 103), a 5-hydroxytryptamine(2A) receptor inverse agonist.

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

mRNAs for clozapine-sensitive receptors co-localize in rat prefrontal cortex neurons

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Cognitive improvement in schizophrenic patients does not require a serotonergic mechanism: randomized controlled trial of olanzapine vs amisulpride

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Object recognition memory: neurobiological mechanisms of encoding, consolidation and retrieval.

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

Implications of animal object memory research for human amnesia.

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

The presynaptic component of the serotonergic system is required for clozapine's efficacy.

1 December 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.180638

1 December 2024

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018